mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.009 |
0.8 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.8 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.0069 |
0.8 |
mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.8 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.8 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.8 |